Format

Send to

Choose Destination
Nat Clin Pract Neurol. 2007 May;3(5):256-63.

Cerebral vasospasm after subarachnoid hemorrhage: the emerging revolution.

Author information

1
Division of Neurosurgery at St Michael's Hospital, University of Toronto, Toronto, Canada. macdonaldlo@smh.toronto.on.ca

Abstract

Cerebral vasospasm is the classic cause of delayed neurological deterioration after aneurysmal subarachnoid hemorrhage, leading to cerebral ischemia and infarction, and thus to poor outcome and occasionally death. Advances in diagnosis and treatment-principally the use of nimodipine, intensive care management, hemodynamic manipulations and endovascular neuroradiology procedures-have improved the prospects for these patients, but outcomes remain disappointing. Recent clinical trials have demonstrated marked prevention of vasospasm with the endothelin receptor antagonist clazosentan, yet patient outcome was not improved. This Review considers possible explanations for this result and proposes alternative causes of neurological deterioration and poor outcome after subarachnoid hemorrhage, including delayed effects of global cerebral ischemia, thromboembolism, microcirculatory dysfunction and cortical spreading depression.

PMID:
17479073
DOI:
10.1038/ncpneuro0490
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center